Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
| 161 | 3 | MENOPAUSE//ISOFLAVONES//TAMOXIFEN | 62578 |
| 552 | 2 | TAMOXIFEN//ESTROGEN RECEPTOR//AROMATASE INHIBITORS | 15141 |
| 22765 | 1 | ENDOXIFEN//TAMOXIFEN//CYP2D6 | 391 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | ENDOXIFEN | authKW | 4334725 | 17% | 81% | 66 |
| 2 | TAMOXIFEN | authKW | 665972 | 49% | 4% | 191 |
| 3 | CYP2D6 | authKW | 521213 | 22% | 8% | 85 |
| 4 | N DESMETHYLTAMOXIFEN | authKW | 474138 | 3% | 59% | 10 |
| 5 | TAMOXIFEN N OXIDE | authKW | 241815 | 1% | 100% | 3 |
| 6 | 4 HYDROXYTAMOXIFEN | authKW | 217680 | 4% | 16% | 17 |
| 7 | LSU STANLEY SCOTT CANC | address | 161210 | 1% | 100% | 2 |
| 8 | NORENDOXIFEN | authKW | 161210 | 1% | 100% | 2 |
| 9 | TAMOXIFEN METABOLISM | authKW | 161206 | 1% | 50% | 4 |
| 10 | CYP2D6 INHIBITOR | authKW | 145086 | 1% | 60% | 3 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Oncology | 3087 | 46% | 0% | 181 |
| 2 | Pharmacology & Pharmacy | 1260 | 34% | 0% | 133 |
| 3 | Medical Laboratory Technology | 186 | 4% | 0% | 15 |
| 4 | Chemistry, Medicinal | 76 | 5% | 0% | 19 |
| 5 | Chemistry, Analytical | 56 | 7% | 0% | 26 |
| 6 | Biochemical Research Methods | 24 | 4% | 0% | 14 |
| 7 | Toxicology | 23 | 3% | 0% | 12 |
| 8 | Obstetrics & Gynecology | 17 | 3% | 0% | 11 |
| 9 | Genetics & Heredity | 15 | 4% | 0% | 16 |
| 10 | Medicine, Research & Experimental | 7 | 3% | 0% | 11 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | LSU STANLEY SCOTT CANC | 161210 | 1% | 100% | 2 |
| 2 | ADV STUDIES CATEDRA FLORENCIO TEJERINA | 80605 | 0% | 100% | 1 |
| 3 | BREAST CANC SUSCEPTIBIL PHARMACOGEN | 80605 | 0% | 100% | 1 |
| 4 | BREAST ZURICH | 80605 | 0% | 100% | 1 |
| 5 | CATEDRA FLORENCIO TEJERINA UNIV EUROPEA MADRID | 80605 | 0% | 100% | 1 |
| 6 | CHAIR SEMEIOT CHIRURG | 80605 | 0% | 100% | 1 |
| 7 | CHRISTIAN BARNARD MEM HOSP | 80605 | 0% | 100% | 1 |
| 8 | COMPUT SYST BIOL | 80605 | 0% | 100% | 1 |
| 9 | DANIEL CANC GENOM | 80605 | 0% | 100% | 1 |
| 10 | DANIEL DEN HOOD CANC | 80605 | 0% | 100% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | BREAST CANCER RESEARCH AND TREATMENT | 21923 | 12% | 1% | 45 |
| 2 | PHARMACOGENOMICS | 7414 | 3% | 1% | 13 |
| 3 | CLINICAL PHARMACOLOGY & THERAPEUTICS | 2652 | 4% | 0% | 14 |
| 4 | PERSONALIZED MEDICINE | 2307 | 1% | 1% | 4 |
| 5 | PHARMACOGENETICS AND GENOMICS | 1721 | 1% | 0% | 5 |
| 6 | JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1305 | 2% | 0% | 7 |
| 7 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1061 | 3% | 0% | 10 |
| 8 | DRUG METABOLISM AND PHARMACOKINETICS | 959 | 1% | 0% | 3 |
| 9 | BREAST CANCER RESEARCH | 891 | 1% | 0% | 5 |
| 10 | PHARMACOGENOMICS JOURNAL | 856 | 1% | 0% | 3 |
Author Key Words |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | ENDOXIFEN | 4334725 | 17% | 81% | 66 | Search ENDOXIFEN | Search ENDOXIFEN |
| 2 | TAMOXIFEN | 665972 | 49% | 4% | 191 | Search TAMOXIFEN | Search TAMOXIFEN |
| 3 | CYP2D6 | 521213 | 22% | 8% | 85 | Search CYP2D6 | Search CYP2D6 |
| 4 | N DESMETHYLTAMOXIFEN | 474138 | 3% | 59% | 10 | Search N+DESMETHYLTAMOXIFEN | Search N+DESMETHYLTAMOXIFEN |
| 5 | TAMOXIFEN N OXIDE | 241815 | 1% | 100% | 3 | Search TAMOXIFEN+N+OXIDE | Search TAMOXIFEN+N+OXIDE |
| 6 | 4 HYDROXYTAMOXIFEN | 217680 | 4% | 16% | 17 | Search 4+HYDROXYTAMOXIFEN | Search 4+HYDROXYTAMOXIFEN |
| 7 | NORENDOXIFEN | 161210 | 1% | 100% | 2 | Search NORENDOXIFEN | Search NORENDOXIFEN |
| 8 | TAMOXIFEN METABOLISM | 161206 | 1% | 50% | 4 | Search TAMOXIFEN+METABOLISM | Search TAMOXIFEN+METABOLISM |
| 9 | CYP2D6 INHIBITOR | 145086 | 1% | 60% | 3 | Search CYP2D6+INHIBITOR | Search CYP2D6+INHIBITOR |
| 10 | METABOLITE LEVELS | 143293 | 1% | 44% | 4 | Search METABOLITE+LEVELS | Search METABOLITE+LEVELS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |